Veterinary Medicines

FELIVAC PCHR ενέσιμο γαλάκτωμα για γάτες

Authorised
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
  • Feline calicivirus, strain FCV F9 Bio-8, Inactivated
  • Felid herpesvirus 1, strain FHV-1 Bio-9, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Download as PDF

Product identification

Medicine name:
FELIVAC PCHR ενέσιμο γαλάκτωμα για γάτες
Active substance:
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
  • Feline calicivirus, strain FCV F9 Bio-8, Inactivated
  • Felid herpesvirus 1, strain FHV-1 Bio-9, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain FCV F9 Bio-8, Inactivated
    316228.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain FHV-1 Bio-9, Inactivated
    100000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Candilidis S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 51465/18-05-2022/K-0252601
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."